Keep up to date with the latest developments from CERSI-PGx, including news articles, research publications, workshops, and events. This page provides timely information for researchers, industry professionals, regulators, and the public interested in pharmacogenomics.
- Latest Publications
- Upcoming Events
- Past Events Archive
LinkedIn Feed
News & Events
-
New article title
Subsection title Type in your amazing paragraph. Read the Full Guideline: For a deeper dive into the clinical recommendations and the implementation of pharmacogenomics in… read article →
-
New CERSI-PGx Clinical Guidelines: Universal CYP2C19 Genotyping for Clopidogrel Prescribing
CERSI-PGx has published comprehensive UK clinical guidelines recommending universal CYP2C19 genotype testing for patients prescribed clopidogrel. Covering stroke, coronary artery disease, and peripheral arterial disease,… read article →
-
UK Launches CERSI-PGx to Revolutionise Pharmacogenomics and Patient Safety
The UK has officially launched the Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) to accelerate the adoption of personalized medicine. Led… read article →
-
Free eLearning Portal Launched to Empower Healthcare Professionals with Genomic Literacy
The Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) has launched a new, free eLearning portal to bridge the gap between genomic… read article →
-
CERSI-PGx Launches New eLearning Portal to Support Clinical Pharmacogenomics
We are pleased to share the official launch of the CERSI-PGx eLearning Portal → Developed by the Centre of Excellence in Regulatory Science and Innovation… read article →
-
CERSI-PGx Workshop: Showcasing Outcomes and Shaping the Future of Pharmacogenomics
We are delighted to invite stakeholders, industry partners, and healthcare professionals to the CERSI-PGx Workshop: Outcomes and Next Steps. Taking place on 20–21 January 2026… read article →
Learn more about each work package →
- WP1 – Developing UK-Based Guidelines
- WP2 – Pathway for Industry Pharmacogenomic Testing
- WP3 – Education and Training
- WP4 – Health Economics of PGx
- WP5 – Patient and Public Engagement